Arvinas Inc.
5 Science Park
395 Winchester Ave
New Haven
Connecticut
06511
United States
91 articles with Arvinas Inc.
-
Arvinas To Present Data At The 2016 AACR Annual Meeting
4/14/2016
-
Arvinas Appoints Angela Shen As Chief Medical Officer
3/2/2016
-
Arvinas Presents Data At The 2015 American Society of Hematology Annual Meeting
12/3/2015
-
Arvinas Secures $41.6 Million Series B Financing - Appoints New Board Members
10/21/2015
-
Arvinas Inks $300 Million Deal With Genentech Over Protein Degradation Technology
10/2/2015
-
Arvinas Appoints Robert Kleinfield As Chief Development Officer
9/23/2015
-
Arvinas Publishes First Peer-Reviewed Paper On Its Proprietary PROTAC Technology
6/5/2015
-
Arvinas Strikes $434 Million Collaboration with Merck & Co. to Continue Thriving in Connecticut
4/8/2015
-
Arvinas Appoints Manuel Litchman As President And Chief Executive Officer
1/12/2015
-
Arvinas Hires Jim Winkler As Chief Scientific Officer
2/10/2014
-
Yale University Spinout Arvinas Lands $18.25 Million to Advance Clinical Programs Focused on Protein Degradation
9/27/2013